Our results after MAVS knockdown suggest that either RIG-I or MDA5 is involved in the CXCL10 secretion by cancer cells and that the TLR3 pathway contributes at least as much to CXCL10 secretion as the MAVS pathway. This evidence concerns the gene MAVS and cancer.